Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Siemens healthcare diagnostics has observed that specific lots of the siemens aptt reagent dade actin fsl activated ptt reagent show an increase in heparin sensitivity over the shelf life. this increased heparin sensitivity prolongs the activated partial thromboplastin times (aptt) which may lead to a decision to decrease the anticoagulation dosage increasing the risk of thromboembolism.